Search

CareDx Inc

Slēgts

SektorsVeselības aprūpe

53.48 -1

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

53.01

Max

55.11

Galvenie mērījumi

By Trading Economics

Ienākumi

108M

111M

Pārdošana

14M

132M

P/E

Sektora vidējais

25.178

56.432

EPS

0.17

Peļņas marža

83.848

Darbinieki

761

EBITDA

-3.8M

4.3M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

-4.39% downside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 3. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

831M

2.7B

Iepriekšējā atvēršanas cena

54.48

Iepriekšējā slēgšanas cena

53.48

Ziņu noskaņojums

By Acuity

100%

0%

321 / 339 Rangs Healthcare

CareDx Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 16. sept. 20:10 UTC

CareDx Inc shares are advancing, closing at a notable high and remaining well above their 20-day moving average since Tuesday's close.

2026. g. 15. sept. 20:07 UTC

CareDx Inc shares are higher today, even as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.

2026. g. 14. sept. 20:07 UTC

CareDx Inc shares are higher today, continuing a notable gain since Friday's close and reaching a session high earlier. No specific news was identified.

2026. g. 12. sept. 00:01 UTC

CareDx Inc shares are higher in after-market hours, with no specific news driving the move. The broader market reflects inflation data and interest rate speculation.

2026. g. 11. sept. 20:08 UTC

CareDx Inc. shares are higher today, reflecting a broader market trend. The stock remains above its 20-day moving average, indicating relative strength.

2026. g. 8. sept. 20:07 UTC

CareDx Inc shares are declining today amid broader market trends. The stock reached a session low earlier, remaining lower since Friday's close.

2026. g. 2. sept. 20:08 UTC

News

Canaccord Genuity initiated coverage on CareDx with a Buy rating and a $65 price target, contributing to the stock's upward movement during the session.

2026. g. 1. sept. 20:09 UTC

CareDx Inc shares are lower amid a broader market downturn. Investors are responding to macroeconomic concerns, including rising oil prices and inflation worries.

2026. g. 31. aug. 20:07 UTC

CareDx Inc shares are higher, recovering from an early dip amid broader market volatility and macroeconomic concerns regarding inflation and interest rates.

2026. g. 28. aug. 23:56 UTC

CareDx Inc shares are higher in after-market hours, reflecting a generally strong performance backdrop amid rising market expectations for a potential interest rate hike.

2026. g. 27. aug. 19:51 UTC

Shares of CareDx Inc. are advancing amid unusually high trading volume. Earlier in the session, shares pulled back from a session high.

2026. g. 26. aug. 20:08 UTC

CareDx Inc shares are higher today, regaining momentum after earlier pulling back. The broader market reflects mixed performance amid recent inflation data.

2026. g. 25. aug. 20:07 UTC

CareDx Inc. shares are higher today, reflecting a strong upward move since Monday amid easing Treasury yields that support equities and investor sentiment.

2026. g. 24. aug. 19:26 UTC

Social Media

CareDx Inc shares are lower today, despite social media discussions projecting a price target of $75 by 2027 and expected revenues of $575 million.

2026. g. 21. aug. 23:01 UTC

CareDx Inc shares are higher in after-market trading, reflecting notable activity despite broader market volatility and no specific company news identified.

2026. g. 20. aug. 20:06 UTC

CareDx Inc. shares are higher, recovering from an earlier pullback, amid rising crude oil prices and increased U.S. Treasury yields influencing market dynamics.

2026. g. 19. aug. 23:56 UTC

CareDx Inc shares are higher in after-market hours, remaining above their 20-day moving average. No specific news was identified to explain the movement.

2026. g. 18. aug. 20:04 UTC

CareDx Inc shares are lower today, reflecting broader market trends amid rising U.S. Treasury yields and inflation concerns. The stock remains down since Monday's close.

2026. g. 14. aug. 20:02 UTC

CareDx Inc shares are lower today amid notable volatility. A recent report showed an unexpected drop in U.S. retail sales, impacting broader market sentiment.

2026. g. 12. aug. 19:36 UTC

CareDx Inc. shares are lower today, reflecting a slight decline since Tuesday's close, despite earlier rebounding from a session low.

2026. g. 11. aug. 23:41 UTC

CareDx Inc shares advanced in after-market trading, reflecting notable gains since Tuesday's close. The stock remains well above its 20-day moving average.

2026. g. 10. aug. 23:46 UTC

CareDx Inc shares are higher in after-market hours, trading significantly above their 20-day moving average and near the upper end of their one-month range.

2026. g. 7. aug. 20:06 UTC

CareDx Inc shares are higher today, recovering from an early dip. The stock has gained significantly since Thursday amid a decline in Treasury yields.

2026. g. 5. aug. 19:46 UTC

Shares of CareDx Inc. are lower today amid unusual volatility, reflecting a broader market sentiment influenced by disappointing employment data from ADP.

2026. g. 4. aug. 21:36 UTC

CareDx Inc shares are higher in after-market trading, reflecting a broader U.S. stock rally amid declining crude oil prices easing inflation concerns.

2026. g. 3. aug. 20:02 UTC

News

CareDx Inc shares rise following a rating upgrade to Buy from Craig-Hallum and a new price target of $64, up from $35.

2026. g. 31. jūl. 23:06 UTC

News

CareDx shares are lower in after-market hours despite a 52% revenue increase to $132 million and raised full-year guidance to $490 million-$500 million.

2026. g. 30. jūl. 23:41 UTC

News

CareDx Inc reported second-quarter revenue of $132 million, exceeding estimates. Following strong results and raised guidance, shares are higher in after-market trading.

2026. g. 29. jūl. 19:56 UTC

CareDx Inc shares are lower, continuing a six-session decline amid rising crude oil prices and inflation concerns affecting broader market sentiment.

2026. g. 27. jūl. 19:16 UTC

News

CareDx Inc is trading lower today, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

Salīdzinājums

Cenas izmaiņa

CareDx Inc Prognoze

Cenas mērķis

By TipRanks

-4.39% uz leju

Prognoze 12 mēnešiem

Vidējais 51.2 USD  -4.39%

Augstākais 65 USD

Zemākais 21 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CareDx Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

3

Pirkt

3

Turēt

0

Pārdot

Noskaņojums

By Acuity

321 / 339 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.